Physician profile
Eric Yoon
NPI 1417992199
$4,239.27
in general payments reported to CMS, 2019-2025
25 companies · $1,245 in 2025
The $1,245 reported for 2025 was more than what 82% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $755 · 2020: $156 · 2021: $357 · 2022: $591 · 2023: $726 · 2024: $408 · 2025: $1,245.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,142 · Travel and Lodging: $238.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,141.72 |
| Travel and Lodging | $238.06 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $1,101.98 | 2019-2025 | Rocklatan, Argos, Tryptyr |
| Bausch & Lomb Americas INC. | $509.09 | 2022-2025 | Miebo, Xiidra, Vyzulta |
| Oyster Point Pharma, INC. | $320.85 | 2022-2024 | Tyrvaya |
| Sun Pharmaceutical Industries INC. | $263.88 | 2019-2025 | |
| Allergan, INC. | $239.85 | 2019-2022 | |
| Stryker Corporation | $238.06 | 2025 | Alphavent |
| Dutch Ophthalmic, USA | $212.68 | 2023 | Eva, Combined Machine, Tissueblue |
| Kala Pharmaceuticals, INC. | $205.22 | 2019-2021 | |
| Zimmer Biomet Holdings, INC. | $187.30 | 2025 | Persona |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $178.40 | 2019-2021 | |
| Abbvie INC. | $107.82 | 2022-2025 | |
| Novartis Pharmaceuticals Corporation | $107.70 | 2020-2023 | |
| Aerie Pharmaceuticals, INC. | $103.60 | 2020-2021 | |
| Rayner Intraocular Lenses Limited | $74.32 | 2023-2025 | Rayone Emv, Rayone Spheric, Rayone Aspheric |
| Dompe US, INC. | $73.85 | 2024-2025 | Oxervate |
Show all 25 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tarsus Pharmaceuticals, INC. | $68.06 | 2024-2025 | Xdemvy |
| Johnson & Johnson Surgical Vision, INC. | $65.28 | 2021-2025 | |
| Harrow Eye, LLC | $37.59 | 2025 | Vevye |
| Ocular Therapeutix, INC. | $31.57 | 2020 | |
| Boston Scientific Corporation | $24.72 | 2025 | Resolution 360 Clip |
| Thea Pharma INC. | $21.47 | 2025 | Iyuzeh |
| Carl Zeiss Meditec Ag | $19.40 | 2020 | |
| Sight Sciences, INC. | $19.18 | 2021 | |
| Shire North American Group INC | $15.12 | 2019 | |
| Glaukos Corporation | $12.28 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Eric Yoon listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.